« Return to News | CROs/Service Providers

Molecular Profiles invests $14.3 million in new facility in Nottingham

Tuesday, March 6, 2012 06:00 AM

Molecular Profiles, a contract research and manufacturing organization, has begun construction of a new manufacturing facility in Nottingham, U.K.

The $14.3 million investment will allow Molecular Profiles to expand its current manufacturing capabilities. The U.K. government allocated a regional growth fund grant of $2.5 million. 

The new GMP facility, planned to open in late 2012, will provide an additional 30,000 square feet of space consisting of six new GMP suites, several laboratories and a clinical packing suite. The facility will enable flexibility of use and the manufacture of highly potent compounds up to OEB 4 level. It is also designed to handle a range of dosage forms including solids, liquids, semi-solids and inhaled products. The expanded capability allows Molecular Profiles to comprehensively cover phase I and II clinical trial requirements with manufacturing batch scale of up to 30kg.

The investment will enable expansion across all Molecular Profiles’ services, including formulation development, polymorph and salt selection, analytical services, materials characterization and clinical trial manufacturing.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.